133 related articles for article (PubMed ID: 37089085)
1. Severe lupus flare is associated with a much higher risk of stroke among patients with SLE.
Chang KC; Lin CH; Chen PL; Wu YH; Hou CW; Huang JA
Int J Stroke; 2023 Oct; 18(8):957-964. PubMed ID: 37089085
[TBL] [Abstract][Full Text] [Related]
2. Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus.
Huang JA; Lin CH; Wu MJ; Chen YH; Chang KC; Hou CW
Stroke Vasc Neurol; 2024 Feb; 9(1):1-7. PubMed ID: 37169398
[TBL] [Abstract][Full Text] [Related]
3. Risks, subtypes, and hospitalization costs of stroke among patients with systemic lupus erythematosus: a retrospective cohort study in Taiwan.
Wang IK; Muo CH; Chang YC; Liang CC; Lin SY; Chang CT; Yen TH; Chuang FR; Chen PC; Huang CC; Sung FC
J Rheumatol; 2012 Aug; 39(8):1611-8. PubMed ID: 22753653
[TBL] [Abstract][Full Text] [Related]
4. Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.
Torres-Ruiz J; Barrera-Vargas A; Ortiz-Hernández R; Alcocer-Varela J; Ponce-de-León A; Gómez-Martín D
Lupus; 2018 Feb; 27(2):312-318. PubMed ID: 28699377
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
Fernandez-Ruiz R; Bornkamp N; Kim MY; Askanase A; Zezon A; Tseng CE; Belmont HM; Saxena A; Salmon JE; Lockshin M; Buyon JP; Izmirly PM
Arthritis Res Ther; 2020 Aug; 22(1):191. PubMed ID: 32807233
[TBL] [Abstract][Full Text] [Related]
6. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
7. Disease Activity and Rate and Severity of Flares During Peripartum Period in Thai Patients With Systemic Lupus Erythematosus: An Age at Diagnosis and Disease Duration Matched Controlled Study.
Louthrenoo W; Trongkamolthum T; Kasitanon N; Wongthanee A
J Clin Rheumatol; 2022 Mar; 28(2):e473-e479. PubMed ID: 34176885
[TBL] [Abstract][Full Text] [Related]
8. Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.
Su L; Qi Z; Guan S; Wei L; Zhao Y
Front Immunol; 2022; 13():978910. PubMed ID: 36238309
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study.
Chiu CC; Huang CC; Chan WL; Chung CM; Huang PH; Lin SJ; Chen JW; Leu HB
Intern Med; 2012; 51(1):17-21. PubMed ID: 22214618
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study.
Su CF; Lai CC; Li TH; Chang YF; Lin YT; Chen WS; Tsao YP; Wang WH; Chang YS; Tsai CY
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211058502. PubMed ID: 34840609
[TBL] [Abstract][Full Text] [Related]
11. Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis.
Nakai T; Kitada A; Fukui S; Okada M
Lupus; 2021 Aug; 30(9):1415-1426. PubMed ID: 34013819
[TBL] [Abstract][Full Text] [Related]
12. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
13. Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay.
Aldarmaki R; Al Khogali HI; Al Dhanhani AM
Lupus; 2021 Apr; 30(5):845-851. PubMed ID: 33497303
[TBL] [Abstract][Full Text] [Related]
14. Systemic Lupus Erythematosus and Risk of Dry Eye Disease and Corneal Surface Damage: A Population-Based Cohort Study.
Tseng CH; Tai YH; Hong CT; Dai YX; Chen TJ; Cherng YG; Lai SC
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900786
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies.
Lin CY; Shih CC; Yeh CC; Chou WH; Chen TL; Liao CC
Int J Cardiol; 2014 Oct; 176(3):847-51. PubMed ID: 25156834
[TBL] [Abstract][Full Text] [Related]
16. Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.
Rossides M; Simard JF; Svenungsson E; von Euler M; Arkema EV
J Rheumatol; 2017 Nov; 44(11):1590-1596. PubMed ID: 28916550
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
Pastore DEA; Costa ML; Surita FG
Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
[TBL] [Abstract][Full Text] [Related]
18. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal trends of systemic lupus erythematous hospitalizations in the United States: a two-decade population-based study.
Edigin E; Trang A; Ojemolon PE; Eseaton PO; Shaka H; Kichloo A; Bazuaye EM; Okobia NO; Okobia RI; Sandhu V; Manadan A
Clin Rheumatol; 2023 Mar; 42(3):695-701. PubMed ID: 36287285
[TBL] [Abstract][Full Text] [Related]
20. Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome.
Guraieb-Chahín P; Cantú-Brito C; Soto-Mota A; Guerrero-Torres L; Flores-Silva F; Chiquete E; Fragoso-Loyo H; González-Duarte A; Valdés-Ferrer SI
Lupus; 2020 Apr; 29(5):437-445. PubMed ID: 32151182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]